. The concept that the positive feedback effect of ovarian estradiol (E 2 ) results in GnRH and gonadotropin surges is a well-established principle. However, a series of studies investigating the rapid action of E 2 in female rhesus monkeys has led to a new concept that neuroestradiol, synthesized and released in the hypothalamus, also contributes to regulation of the preovulatory GnRH surge. This unexpected finding started from our surprising observation that E 2 induces rapid stimulatory action in GnRH neurons in vitro. Subsequently, we confirmed that a similar rapid stimulatory action of E 2 occurs in vivo. Unlike subcutaneous injection of E 2 benzoate (EB), a brief (10-20 min), direct infusion of EB into the median eminence in ovariectomized (OVX) female monkeys rapidly stimulates release of GnRH and E 2 in a pulsatile manner, and the EB-induced GnRH and E 2 release is blocked by simultaneous infusion of the aromatase inhibitor, letrozole. This suggests that stimulated release of E 2 is of hypothalamic origin. To further determine the role of neuroestradiol we examined the effects of letrozole on EBinduced GnRH and LH surges in OVX females. Results indicate that letrozole treatment greatly attenuated the EB-induced GnRH and LH surges. Collectively, neuroestradiol released from the hypothalamus appears to be necessary for the positive feedback effect of E 2 on the GnRH/LH surge.
Introduction
In addition to the gonads, the brain is one of the major organs that synthesizes estradiol (E 2 ). For over 4 decades, a role of E 2 in the regulation of neuronal function has been predicted. As early as 1971, Naftolin and colleagues reported that aromatase, the enzyme that converts androgens to E 2 , is present in the hypothalamus: Incubation of diencephalon obtained from male human fetuses with radiolabeled androstenedione yielded E 2 and estrone (Naftolin et al., 1971) . Subsequently, several pioneers in the field reported the presence of aromatase in the brain (Selmanoff et al., 1977; Steimer and Hutchison, 1980; Ellinwood et al., 1984; MacLusky et al., 1986; Roselli et al., 1987; Roselli et al., 2001) and have speculated about possible roles of neuroestrogens in brain functions as a neurotransmitter or neuromodulator (see Balthazart and Ball, 2006; Saldanha et al., 2011) . This speculation is based on the facts that 1) E 2 induces rapid changes in neuronal activity and behaviors (Yagi, 1973; Kelly et al., 1976; Hojo et al., 2008; Cross and Roselli, 1999; Cornil et al., 2005 Cornil et al., & 2006 Kow and Pfaff, 2004; Remage-Healey et al., 2011) , and 2) aromatase is present in axon terminals and the presynaptic boutons of the brain in various animals including monkeys and humans (Naftolin et al., 1996; Hojo et al., 2004; Peterson et al., 2005) . In 2008, Remage-Healey et al. (2008) reported the most convincing evidence for neuroestradiol release in the songbird auditory cortex by direct in vivo measurements showing that local E 2 concentration increased when the male bird is exposed to another male's songs.
Ovarian E 2 is indispensable for female reproductive functions. E 2 is also known to facilitate learning/memory and protect from neuronal cell death throughout life (Morrison et al., 2006; Spencer et al., 2008; Brinton, 2009) . Although a possible role of neuroestradiol in sex behavior, learning/memory, and neuroprotective function has been conceptually accepted, it has been completely ignored in reproductive neuroendocrinology. Perhaps, this is due to the well-established concept that reproductive cycles are regulated by the hypothalamo-pituitary-gonadal feedback circuit. However, while we were studying the rapid action of E 2 on GnRH neurons, we almost accidentally found that neuroestradiol is significantly important for pulsatile release of GnRH and the preovulatory GnRH surge. In this review, I summarize a recent series of the findings in my laboratory supporting the concept that neuroestradiol participates in the control of GnRH secretion. olfactory placode, we found that E 2 induces rapid excitatory action on GnRH neurons. First, we observed that E 2 at a 1 nM concentration stimulates firing activity of GnRH neurons within 60-120 s, lasting over 25 min (Abe and Terasawa, 2005 (Abe et al., 2008; Noel et al., 2008) . Third, exposure of GnRH neurons to E 2 (1 nM) also stimulates GnRH release within 10 min (Noel et al., 2008) . This rapid E 2 action on GnRH neurons appears to be direct, as our primary cultures of GnRH neurons usually do not contain other types of neurons or glia, although numerous fibroblasts, epithelial cells, and unidentified non-neuronal cells are present (Terasawa et al., 1993; Richter et al., 2002) . Together, we concluded that E 2 induces a direct rapid excitatory action on primate GnRH neurons. Rapid action of E 2 on GnRH neurons has been known for some time. E 2 hyperpolarizes guinea pig GnRH neurons, alters cAMP production in GT1-cells and stimulates or inhibits [Ca 2+ ] i oscillations within 15 min (Lagrange et al., 1995; Navarro et al., 2003; Temple et al., 2004; Romanò et al., 2008) . Importantly, all these studies including ours were conducted in in vitro systems, such as cultured GnRH neurons or sliced brains. Thus, the question arises as to whether "rapid E 2 action" seen in in vitro studies also occurs in vivo?
The negative and positive feedback effects of E 2 on GnRH/LH release are well-established concepts. For example, systemic administration of E 2 benzoate (EB) in OVX monkeys results in suppression of GnRH/LH release with a latency of~2 h (Mizuno and Terasawa, 2005) , whereas stimulatory action occurs with a latency of~24 h (Yamaji et al., 1971; Karsch et al., 1973; Terasawa et al., 1982) . However, there was so far no report showing that rapid action of E 2 on GnRH release occurs with a latency shorter than 20 min in vivo in any mammalian species. Therefore, we examined the effects of a brief EB infusion into the median eminence of the hypothalamus on GnRH release using a microdialysis approach. In the monkey dense GnRH neuroterminals and some GnRH cell bodies are distributed in the median eminence (Goldsmith et al., 1993) . Continuous infusion of EB stimulated, not suppressed, GnRH release in ovariectomized (OVX) monkeys in vivo within 10-20 min, similar to what had been seen in vitro (Fig. 1 , Kenealy et al., 2013) . Furthermore, a similar brief infusion of EB also stimulated kisspeptin release (see Kenealy et al., 2015) . Kisspeptin neuroterminals and cell bodies are also seen in the median eminence (Ramaswamy et al., 2008) .
These findings led to another question: What is the underlying mechanism differentiating the E 2 action resulting from the 2 modes of EB administration (systemic injection vs. local infusion to the median eminence)? There are at least 3 possible explanations. First, the difference may be due to the exposure period of the median eminence to E 2 . While the exposure period in the study of Kenealy et al. (2013) was 10-20 min, systemic EB injection would sustain elevated circulating levels for at least 18 h. Second, the difference may be due to the E 2 concentration at the median eminence. While the EB exposure dose in the study by Kenealy et al. (2013) was 1 or 10 nM, in systemic injection we used 50 μg/kg and the local concentration produced in the median eminence is unknown. Third, the difference may be attributable to the site of action within the hypothalamus.
The results from a subsequent study indicate that the exposure period does not account for the difference in the 2 modes of EB administration: EB infusion into the median eminence for a prolonged period (4 or 7 h) sustains elevated release of GnRH and kisspeptin over several hours (Fig. 2 , Kenealy et al., 2015) , similar to the release observed with a brief (10 or 20 min) infusion (Kenealy et al., 2013, Fig. 1) . Likewise, the EB concentration at the median eminence does not likely differentiate the 2 modes of EB administration. Continuous or brief infusion of EB at doses ranging from 1 nM to 1 μM, which translates into one tenth of the concentration (0.1 to 100 nM) in the tissue at the median eminence due to the permeability of microdialysis membrane (Frost et al., 2008) , stimulated release of GnRH and kisspeptin, whereas subcutaneous injection of EB at 50 μg/kg, which induces concentrations of 300 to 500 pg/ml or 1-1.5 nM in the circulation (Mizuno and Terasawa, 2005) suppressed both GnRH and kisspeptin release (Kenealy et al., 2015) . In contrast, the site of EB exposure is critical for stimulating the release of GnRH and kisspeptin by EB. In the EB infusion experiment, the region exposed to EB is restricted within the median eminence, as the tips of microdialysis probes (determined by x-ray ventriculography) are all located within the median eminence (Kenealy et al., 2015) , whereas systemically administered EB reaches a large portion of the brain as well as the pituitary gland, as shown by autoradiography (Pfaff et al., 1976) . It is speculated that systemically administered EB binds to estrogen receptor alpha (ERα, ESR1) located in infundibular (arcuate) kisspeptin and neurokinin-B neurons (Rance, 2009 ) resulting in inhibitory action, whereas direct infusion of EB into the GnRH and kisspeptin neuroterminals induces rapid actions mediated through a membrane-initiated mechanism.
Previously, we have shown that rapid action of E 2 in vitro is mediated through two E 2 membrane receptors, GPR30 (GPER1) and the STXsensitive membrane receptors (Noel et al., 2008; Kenealy et al., 2011a Kenealy et al., & 2011b . This is significantly different from receptors implicated in the positive and negative feedback effects of E 2 . The feedback regulation of E 2 requires estrogen receptor ERα (ESR1) or ERβ (ESR2), through which E 2 activates nuclear transcription with a longer latency (see Herbison, 2015) . As discussed in the following sections, regulation of GnRH neurosecretory activity by neuroestradiol occurs as a rapid E 2 action.
Role of neuroestradiol in pulsatile GnRH release
During the course of the experiments examining the rapid action of E 2 on GnRH release in vivo, we assessed the pattern of local E 2 levels as a consequence of EB injection. Results indicate that E 2 release in response to EB challenge, measured by liquid chromatography followed by tandem mass-spectrometry (LC/MS/MS), is pulsatile (Fig. 3) . The pulsatile release pattern of E 2 was rather surprising to us, as we were used to seeing an asymmetric bell shape pattern in circulating E 2 after systemic injection of EB, i.e., E 2 rapidly increases reaching a plateau, and then slowly returns to the pre-injection level, because the E 2 radioimmunoassay is cross-reacting with EB. We soon realized that LC/ MS/MS distinguishes E 2 from EB because of its different mass-to-charge ratios, such that infusion of EB into the median eminence must have induced local release of E 2 . If the hypothalamus releases E 2 in response to an EB infusion, we should also be able to observe the release without EB treatment. Indeed, we found that electrical stimulation of the medial basal hypothalamus (MBH) of OVX monkeys initially suppresses and then stimulates E 2 release (Kenealy et al., 2013) .
In addition, if the EB-induced E 2 release is of hypothalamic origin, we should observe that inhibition of local E 2 synthesis blocks stimulatory EB action. Therefore, we examined the effects of the aromatase inhibitor, letrozole, on the EB-induced GnRH and E 2 release. In this experiment, we infused letrozole (or its vehicle for control) into the median eminence for 100 min, during which EB was also infused for 20 min. The results indicated that in the presence of letrozole EB did not induce E 2 release nor GnRH release, whereas EB induced both GnRH and E 2 increases in the absence of letrozole (Fig. 4 , Kenealy et al., 2013) . Importantly, letrozole also suppressed the EB-induced GnRH release as well as spontaneous GnRH pulses (Fig. 4) . At this point we could have concluded that neuroestradiol plays an important role in regulation of pulsatile GnRH release. However, during the course of the study we found that spontaneous neuroestradiol release in the median eminence of OVX monkeys is rare and that when spontaneous release occurs, the amplitude of peaks is much smaller than for peaks evoked by EB or electrical stimulation (Kenealy et al., 2013) . Therefore, we concluded that the role of neuroestradiol on regulation of pulsatile GnRH release might be limited to certain circumstances and there must be another role of hypothalamic neuroestradiol in GnRH regulation. I will address this issue with the next series of experiments. D) release, or 7 h EB infusion on GnRH (B) and KP (E) release, and vehicle infusion on GnRH (C) and KP (F) release. Mean GnRH release in either the 4 h (p < 0.02, n = 7) or 7 h (p < 0.0001, n = 8) treatment groups was significantly higher than the 2 h respective control period before treatment as well as vehicle control (p < 0.0001 for both, n = 8). Similarly, the EB-induced increase in kisspeptin levels in both the 4 h and 7 h EB infusion treatment groups were significantly higher than the 2 h control period before (p < 0.0001 for both) and vehicle control (p < 0.0001 for both). Bonferroni's post hoc analysis indicates that in 4 h and 7 h EB infusion experiments mean GnRH and KP release are significantly higher than the 2 h period before EB infusion as indicated (*: p < 0.05; **: p < 0.01; ***: p < 0.001 vs. before) and also significantly elevated compared to vehicle control at the corresponding time period as indicated (#: p < 0.05; ##: p < 0.01; ###: p < 0.001 vs. vehicle). From Kenealy et al., 2015 . Permission pending. Grey bars designate the 20-min EB (10 or 100 nM) or vehicle infusion. Note that EB induced increases in GnRH release and pulsatile E 2 release (A). While the amplitude of GnRH responses appears to be EB dose-dependent, the amplitude of E 2 did not vary. In contrast, vehicle infusion does not cause any significant effects (B). In this case, a single spontaneous E 2 peak is seen at 8 h. Arrowheads indicate pulses identified by PULSAR. From Kenealy et al., 2013 . Permission pending.
Role of neuroestradiol in GnRH surge
A rise in ovarian E 2 from the primary follicles is the signal triggering the preovulatory GnRH/LH surge. Using an experimental model, it has been shown that systemic injections of EB to OVX monkeys induce GnRH and LH surges, i.e., sustained GnRH and LH elevations for over 36 h with a latency of~24 h (Levine et al., 1985; Xia et al., 1992; Yamaji et al., 1971; Terasawa, 1985; Schultz and Terasawa, 1988) . Because our observations show that prolonged infusion of EB into the median eminence keeps GnRH release elevated for several hours (Kenealy et al., 2015) and that the sustained elevation of GnRH release is reminiscent of the preovulatory GnRH surge, we hypothesized that neuroestradiol release is necessary for the estrogen-induced LH/GnRH surge.
We tested this hypothesis with two experiments. In the first experiment OVX monkeys implanted with an E 2 capsule (this results in LH levels similar to the level during the follicular phase) were treated with daily injections of letrozole for 1 week and then EB was injected systemically mimicking the preovulatory E 2 increase. Results indicated that while EB injection induced full LH surges in controls, the letrozole treatment greatly attenuated EB-induced LH surges (Fig. 5 , Kenealy et al., 2017) . Importantly, the latency to the LH surge after EB was not affected by letrozole (Kenealy et al., 2017) . These observations suggest that 1) an increase in circulating E 2 triggers the LH surge, but 2) an elevated level of circulating E 2 is insufficient for sustaining LH surges and E 2 synthesized in the hypothalamus and/or pituitary gland is critically important for the EB-induced LH surge.
There are abundant aromatase-expressing cells in the hypothalamus and anterior pituitary gland (MacLusky et al., 1986; Roselli et al., 2001; Galmiche et al., 2006; Kadioglu et al., 2008) . Thus, the activity of aromatase-synthesizing cells might be influenced by circulating E 2 . This view is consistent with a report in female baboons showing that aromatase activity in the amygdala and preopotic area assessed by PET scan with 11 C-vorozole uptake fluctuates during the menstrual cycle (Pareto et al., 2013) .
In the second experiment, we examined whether blocking locally synthesized E 2 in the hypothalamus by letrozole infusion into the median eminence reduces the EB-induced GnRH surge. Although in the previous study (Kenealy et al., 2013) we showed that neuroestradiol in the hypothalamus is involved in regulation of pulsatile GnRH release in OVX females, we had not examined the involvement of neuroestradiol when there is elevated circulating E 2 . In this experiment, we used a single high EB injection model in OVX monkeys for the induction of GnRH surges. Results indicate that EB-induced GnRH surges are attenuated within 60 min of the letrozole infusion into the median eminence (Fig. 6A vs. C, Kenealy et al., 2017) . Similarly, EB-induced kisspeptin surges are also reduced in the presence of letrozole, when compared to those in vehicle control (Fig. 6B vs. D, Kenealy et al.,   2017 ). We speculate that letrozole infusion reduces the EB-induced E 2 release, as shown in the previous study (Kenealy et al., 2013) . We now plan to measure E 2 release in the median eminence in future experiments.
The results from these two experiments provide a new insight into the well-established positive feedback effects of E 2 . An increase in circulating E 2 feeds back to interneurons, such as kisspeptin neurons, that stimulate GnRH neurons resulting in the GnRH surge (Dungan et al., 2007; Clarkson et al., 2008) . At the same time, elevated circulating E 2 stimulates E 2 synthesizing cells in the hypothalamus and locally synthesized neuroestradiol further augments the GnRH surge directly or indirectly through interneurons (Fig. 7B ). This view is quite different from the current view in which an increase in circulating E 2 solely feeds back to kisspeptin neurons, through which GnRH surges are generated (Fig. 7A) .
A small increase in circulating progesterone during the late follicular phase in humans or a progesterone increase after E 2 priming in OVX monkeys defines the timing of the GnRH/LH surge (Clifton et al., 1975; Terasawa et al., 1982; Hoff et al., 1983) . A question arises as to whether GnRH/LH surges augmented by progesterone in the presence of E 2 , are also accompanied by the release of neuroestradiol. Although additional experiments with direct measurements of E 2 in the median eminence are necessary, it is unlikely that progesterone action during the preovulatory phase is affected by letrozole, as letrozole does not influence the latency of the EB-induced LH surge.
The stimulatory role of neuroprogesterone, locally synthesized by hypothalamic astrocytes, in the preovulatory LH surge in female rats has been reported in detail (see Micevych and Sinchak, 2011) . So far, we have not examined the role of neuroprogesterone in the E 2 -induced GnRH surge. Nevertheless, it can be expected that the role of neuroprogesterone in the preovulatory GnRH surge in primates would significantly differ from that reported in rodents. This view is based on the difference in the role of progesterone in the preovulatory surge between rodents and primates. For example, whereas in E 2 -treated OVX female rats progesterone augments the timing and amplitude of the LH surge (DePaolo and Barraclough, 1979) , in primates in E 2 -treated OVX female monkeys progesterone only modifies the timing, but not the overall amplitude, of the LH surge (Terasawa et al., 1980 (Terasawa et al., & 1984 . As a consequence, unlike in rodents, the progesterone-induced LH surge in OVX female monkeys treated with a low dose of E 2 (YTerasawa et al., 1980) does not quite resemble a spontaneous preovulatory LH surge or the LH surge induced by a high dose of E 2 in OVX female monkeys (Yamaji et al., 1971; Karsch et al., 1973) .
Extending the issue of the species differences, the role of neuroestradiol in the preovulatory GnRH/LH surge might be specific to primates or species with a luteal phase. For example, animals with a true luteal phase, such as monkeys and sheep, exhibit a long preovulatory GnRH surge, lasting well after the end of the LH surge (Levine et al., Fig. 4 . An example showing that infusion of letrozole (100 nM, light grey bars) into the median eminence inhibits the EB-induced as well as spontaneous release of GnRH (black line with filled circle) and E 2 (red line with filled square). EB challenge (100 nM, dark grey bars) was first infused for 20 min with vehicle, subsequently letrozole (100 nM, light grey bars) was continuously infused for 100 min, during which EB (100 nM) infusion was added for 20 min (60-80 min after the initiation of letrozole infusion), and finally letrozole (100 nM) alone was infused for 80 min. Note that control EB infusion stimulates release of GnRH and E 2 , whereas EB infusion in the presence of letrozole fails to stimulate release of GnRH or E 2 . Letrozole infusion alone also blocks spontaneous GnRH pulses. From Kenealy et al., 2013 . Permission pending. 1985 Xia et al., 1992; Moenter et al., 1990) . By contrast in rats, which lack the luteal phase, the preovulatory GnRH surge terminates at the same time as the LH surge (Sarkar et al., 1976) . Moreover, in OVX monkeys letrozole greatly attenuates the E 2 -induced GnRH and LH surges (Kenealy et al., 2017) , whereas in OVX aromatase-deficient mice E 2 or E 2 plus progesterone readily induces LH surges (Szymanski and Bakker, 2012) . It is speculated that the prolonged GnRH surge is a result of neuroestradiol and that it might be required for the establishment of the corpus luteum.
Conclusions and perspectives
In this review article, I summarized our findings during the past 15 years showing that E 2 rapidly and directly stimulates GnRH neuronal activity and this rapid action of E 2 has an important implication in the release of GnRH as well as in the local synthesis of E 2 (neuroestradiol) in the hypothalamus. It turns out that neuroestradiol is released in the median eminence and this neuroestradiol release plays an important role in the regulation of pulsatile GnRH release as well as during the estrogen-induced GnRH surge (i.e., preovulatory GnRH surge). Because the preovulatory GnRH surge is the key event for successful pregnancy and contraception, the findings on the role of neuroestradiol in the preovulatory surge potentially open up a new avenue for treatments of fertility and sterility. In fact, brain-specific exon 1 of the human aromatase gene has been reported (Honda et al., 1994) .
The investigation of neuroestradiol in the regulation of reproductive function is just beginning and many questions remain to be answered. Does the release of neuroestradiol in the hypothalamus switch estrogen's action from the negative feedback effect to the positive feedback effect? Is the role of neuroestradiol in the regulation of GnRH release limited to females, given that the male brain generally expresses a higher level of aromatase than the female brain (Roselli and Resko, 1997) ? We previously postulated that neuroestradiol may be a substrate for the "Prepubertal Central Inhibition", as release of neuroestradiol in the median eminence in prepubertal female monkeys is higher than that in early pubertal female monkeys (Kenealy et al., 2016) , but how does neuroestradiol play a role in the suppression of GnRH release? Does neuroestradiol play any role in Alzheimer's disease, as aromatase expression in the hypothalamus in Alzheimer patients is lower than in the age-matched control hypothalamus (Ishunina et al., 2005) . Is neuroestradiol synthesized in neurons, glia, or both? If synthesized in neurons, what is their cell type? We have no data regarding receptors mediating neuroestradiol action in vivo. Unlike genomic estrogen actions mediated through ESR1, rapid actions of E 2 occur through membrane associated estrogen receptors, such as GPER1 (GPR30) (see Terasawa and Kenealy, 2012) , but these studies were conducted in vitro. Finally, why did such a complicated system evolve in primates including actions of E 2 not only from the ovary but also from the brain?
As stated in the Introduction, the role of neuroestadiol has been described for learning and memory, stroke, and in behavioral contexts, such as sex behaviors. Together with current findings on the role of neuroestradiol in the regulation of GnRH release, we are still in the early stages of understanding the role of neuroestradiol in the brain.
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